Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33140540

A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2021 Feb
First author
Wright KD

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Wright KD
      type
      Author
    2. name
      Yao X
      type
      Author
    3. name
      London WB
      type
      Author
    4. name
      Kao PC
      type
      Author
    5. name
      Gore L
      type
      Author
    6. name
      Hunger S
      type
      Author
    7. name
      Geyer R
      type
      Author
    8. name
      Cohen KJ
      type
      Author
    9. name
      Allen JC
      type
      Author
    10. name
      Katzenstein HM
      type
      Author
    11. name
      Smith A
      type
      Author
    12. name
      Boklan J
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Wright KD
      type
      Author
    2. name
      Yao X
      type
      Author
    3. name
      London WB
      type
      Author
    4. name
      Kao PC
      type
      Author
    5. name
      Gore L
      type
      Author
    6. name
      Hunger S
      type
      Author
    7. name
      Geyer R
      type
      Author
    8. name
      Cohen KJ
      type
      Author
    9. name
      Allen JC
      type
      Author
    10. name
      Katzenstein HM
      type
      Author
    11. name
      Smith A
      type
      Author
    12. name
      Boklan J
      type
      Author
    bibliography ids
    1. nci-bib-4419b3c47e46cad76dd74818
    book metadata
    content sha256
    f65bdfb9635244d93ad3c4e391f6eca5bf458d475cc1b847f527ffe23c1bb882
    document type
    citation
    dois
    1. 10.1002/pbc.28787
    electronic publication date
    display
    2020 Nov 2
    precision
    day
    year
    2020
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33140540
    immutable id
    pubmed:33140540@f65bdfb9635244d93ad3c4e391f6eca5bf458d475cc1b847f527ffe23c1bb882
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    2
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    e28787
    volume
    68
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33140540
      provenance
      batch id
      9bca82d1bba2b27adc79
      provider
      NCBI PubMed ESummary
      record sha256
      ee12f62aa27c4a9fe81eb760858636347d0aa3bd8ab46e06b45f85ccb74d35fe
      response sha256
      c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
      retrieved at
      2026-09-09T23:47:56.131551+00:00
      publication date
      display
      2021 Feb
      precision
      month
      year
      2021
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, N.I.H., Extramural
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33140540/
      title
      A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma.

      Preserved source evidence · Not medical advice